C
CardioFocus
We specialize in providing electrophysiologists with innovative and effective tools that bring new levels of precision and control to the treatment of atrial fibrillation
About CardioFocus
CardioFocus, headquartered in Marlborough, MA, specializes in advanced laser technology for the precise treatment of atrial fibrillation (AFib), a type of irregular heartbeat. The company's core product, the HeartLight Endoscopic Ablation System, offers a compliant balloon, direct tissue visualization, and continuous motor-controlled energy delivery, which enhances procedural efficiency and improves patient outcomes. CardioFocus serves healthcare providers, particularly those specializing in cardiac electrophysiology, by offering innovative tools that bring new levels of precision and control to AFib treatment. The company operates in the medical device market and generates revenue through the sale of its specialized ablation systems and related training services. CardioFocus is committed to advancing the science of laser and pulsed field ablation, ensuring durable lesions and successful procedures, thereby optimizing energy delivery across its product portfolio. The company also provides specific training for physicians to ensure the effective use of its systems.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 1990
- Headquarters
- Marlborough, United States
- Employees
- 83
- Open positions
- 3
- Dealroom signal
- 28.7/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Biotechnology, Cardiology and cardiovascular, DT and LS
- Technology
- Hardware, Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| DEBTDebt | Feb 2023 | $16M | — | Undisclosed | ↗ |
| GROWTH EQUITY NON VCOther financing | Feb 2023 | $16M | $275M | Undisclosed | ↗ |
Growth signals
Latest recorded traffic for CardioFocus is 2K monthly website visits, down 23.1% over the last three months. CardioFocus's team declined 3.5% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A7 investors entered at this stage
Boston University
Kestrel Management
MassVentures
Schroders- OPOxford Bioscience Partners
SV Health Investors
Guidant Corporation
Series B and later9 investors entered at this stage
Oxford Finance
Standard Treasury- AVAccuitive Medical Ventures
Aurora Funds
HIG Capital
KBL Healthcare Ventures- MPManatuck Hill Partners
- GHGPB Capital Holdings
Kennedy Lewis Investment Management
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about CardioFocus on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See CardioFocus’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.